81_FR_54741 81 FR 54583 - Advisory Committee for Women's Services; Notice of Meeting

81 FR 54583 - Advisory Committee for Women's Services; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 81, Issue 158 (August 16, 2016)

Page Range54583-54584
FR Document2016-19422

Federal Register, Volume 81 Issue 158 (Tuesday, August 16, 2016) 
[Federal Register Volume 81, Number 158 (Tuesday, August 16, 2016)]
[Notices]
[Pages 54583-54584]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-19422]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Advisory Committee for Women's Services; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of a meeting 
of the Substance Abuse and Mental Health Services Administration's 
(SAMHSA) Advisory Committee for Women's Services (ACWS) on August 24, 
2016.
    The meeting will include discussions on child welfare and substance 
use disorders among families; improving the health of women and girls; 
recovery-oriented systems of care and what they mean for women; 
accountable health communities and how they relate to behavioral 
health; and a conversation with the SAMHSA Deputy of Operations and the 
Chief of Staff.
    The meeting is open to the public and will be held at SAMHSA, 5600 
Fishers Lane, Rockville, MD 20857, in Conference Room 5N76. Attendance 
by the public will be limited to space available. Interested persons 
may

[[Page 54584]]

present data, information, or views, orally or in writing, on issues 
pending before the committee. Written submissions should be forwarded 
to the contact person (below) on or before August 19, 2016. Oral 
presentations from the public will be scheduled at the conclusion of 
the meeting. Individuals interested in making oral presentations are 
encouraged to notify the contact person on or before August 19, 2016. 
Five minutes will be allotted for each presentation.
    The meeting may be accesed via telephone. To attend on site, obtain 
the call-in number and access code, submit written or brief oral 
comments, or request special accommodations for persons with 
disabilities, please register on-line at http://nac.samhsa.gov/Registration/meetingsRegistration.aspx, or communicate with SAMHSA's 
Designated Federal Officer, Ms. Nadine Benton (see contact information 
below).
    Substantive meeting information and a roster of Committee members 
may be obtained either by accessing the SAMHSA Committees' Web site 
http://www.samhsa.gov/about-us/advisory-councils/advisory-committee-womens-services-acws or by contacting Ms. Benton.

    Committee Name: Substance Abuse and Mental Health Services 
Administration Advisory Committee for Women's Services (ACWS).
    Date/Time/Type: Wednesday, August 24, 2016, from: 9:00 a.m. to 
5:00 p.m. EDT, open.
    Place: SAMHSA, 5600 Fishers Lane, Conference Room 5N76, 
Rockville, Maryland 20857.
    Contact: Nadine Benton, Designated Federal Official, SAMHSA's 
Advisory Committee for Women's Services, 5600 Fishers Lane, 
Rockville, Maryland 20857, Telephone: (240) 276-0127, Fax: (240) 
276-2252, Email: [email protected].

Summer King,
Statistician, Substance Abuse and Mental Health, Services 
Administration.
[FR Doc. 2016-19422 Filed 8-15-16; 8:45 am]
 BILLING CODE 4162-20-P

Federal Register / Vol. 81, No. 158 / Tuesday, August 16, 2016 / Notices 54583 Agenda: To review and evaluate grant Email ncitechtransfer@mail.nih.gov. A —First to market potential—No current applications. signed Confidential Disclosure clinical trials with GPC2-targeted Place: National Cancer Institute Shady Agreement may be required to receive therapies Grove, 9609 Medical Center Drive, Room —Human antibody with high specificity copies of the patent applications. 7W030, Rockville, MD 20850, (Telephone Conference Call). SUPPLEMENTARY INFORMATION: and binding to targets results in less Contact Person: Nadeem Khan, Ph.D., Technology description follows. non-specific cell killing, therefore Scientific Review Officer, Research Title of invention: Human Monoclonal fewer potential side-effects for the Technology and Contract Review Branch, Antibodies Targeting Glypican-2 in patient Division of Extramural Activities, National Neuroblastoma. —Small size of single domain Cancer Institute, 9609 Medical Center Drive, antibodies enhances stability, Room 7W260, Rockville, MD 20892–9750, Keywords: Glypican-2, GPC2, solubility, and target recognition 240–276–5856, nadeem.khan@nih.gov. Antibody, Immunotoxin, Recombinant Immunotoxin, RIT, Chimeric Antigen Development Stage: In-vitro. (Catalogue of Federal Domestic Assistance Inventor(s): Mitchell Ho (NCI), et al. Program Nos. 93.392, Cancer Construction; Receptor, CAR, Antibody-drug Intellectual Property: US Provisional 93.393, Cancer Cause and Prevention Conjugate, ADC, bispecific antibody, Application 62/369,861 (HHS Reference Research; 93.394, Cancer Detection and neuroblastoma. Diagnosis Research; 93.395, Cancer No. E–211–2016/0–US–01) filed August Description of Technology: 2, 2016, entitled ‘‘Human Monoclonal Treatment Research; 93.396, Cancer Biology Neuroblastoma is a rare pediatric cancer Research; 93.397, Cancer Centers Support; Antibodies Targeting Glypican-2 in that affects one in every hundred Neuroblastoma.’’ 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, thousand children under the age of Collaboration Opportunity: HHS) fifteen in the United States. Current Researchers at the NCI seek parties standards of care are chemotherapy and interested in licensing or co-developing Dated: August 10, 2016. surgery, followed by stem-cell Melanie J. Gray, GPC2 antibodies and/or conjugates. treatments, radiation and anti- Contact Information: Requests for Program Analyst, Office of Federal Advisory ganglioside antibody therapy, which Committee Policy. copies of the patent application or yield an average three-year survival rate inquiries about licensing, research [FR Doc. 2016–19416 Filed 8–15–16; 8:45 am] of 10–45%. This demonstrates a need collaborations, and co-development BILLING CODE 4140–01–P for more effective therapies. opportunities should be sent to John D. Glypican-2 (GPC2) is a cell surface Hewes, Ph.D., email: john.hewes@ protein that has been shown to be nih.gov. DEPARTMENT OF HEALTH AND preferentially expressed on numerous HUMAN SERVICES Dated: August 8, 2016. pediatric cancers, including neuroblastoma. Due to this preferential John D. Hewes, National Institutes of Health Technology Transfer Specialist, Technology expression, GPC2 represents a potential candidate for targeted therapy. Transfer Center, National Cancer Institute. Government-Owned Inventions; [FR Doc. 2016–19419 Filed 8–15–16; 8:45 am] Availability for Licensing Researchers at the National Cancer Institute’s Laboratory of Molecular BILLING CODE 4140–01–P AGENCY: National Institutes of Health. Biology (NCI LMB) have developed and ACTION: Notice. isolated several single domain monoclonal human antibodies against DEPARTMENT OF HEALTH AND SUMMARY: The invention listed below is GPC2. This technology covers the naked HUMAN SERVICES owned by an agency of the U.S. GPC2 antibodies as well as their use as Government and is available for Substance Abuse and Mental Health targeting domains in recombinant Services Administration licensing and/or co-development in the immunotoxins (RITs) and chimeric U.S. in accordance with 35 U.S.C. 209 antigen receptors (CARs). RITs (using and 37 CFR part 404 to achieve Advisory Committee for Women’s clones LH1, LH4, or LH7) and CARs Services; Notice of Meeting expeditious commercialization of (using LH7) have shown specific killing results of federally-funded research and activity against GPC2-expressing cells, Pursuant to Public Law 92–463, development. Foreign patent suggesting that these candidates may be notice is hereby given of a meeting of applications are filed on selected further developed as therapeutics. the Substance Abuse and Mental Health inventions to extend market coverage Services Administration’s (SAMHSA) The technology has been validated for companies and may also be available Advisory Committee for Women’s with in-vitro studies (human anti-GPC2 for licensing and/or co-development. Services (ACWS) on August 24, 2016. RITs and CARs can bind to, and kill, ADDRESSES: Invention Development and GPC2-positive tumor cells) and the The meeting will include discussions Marketing Unit, Technology Transfer researchers are currently developing on child welfare and substance use Center, National Cancer Institute, 9609 mouse models to further develop GPC2- disorders among families; improving the Medical Center Drive, Mail Stop 9702, targeted therapies. health of women and girls; recovery- Rockville, MD 20850–9702. Potential Commercial Applications: oriented systems of care and what they FOR FURTHER INFORMATION CONTACT: mean for women; accountable health —Therapeutic applications include: Information on licensing and co- communities and how they relate to Unconjugated antibodies, and use as development research collaborations, behavioral health; and a conversation asabaliauskas on DSK3SPTVN1PROD with NOTICES targeting moieties for and copies of the U.S. patent with the SAMHSA Deputy of immunoconjugates such as CARs, applications listed below may be Operations and the Chief of Staff. ADCs, immunotoxins, and bispecific obtained by contacting: Attn. Invention The meeting is open to the public and antibodies Development and Marketing Unit, will be held at SAMHSA, 5600 Fishers Technology Transfer Center, National —Diagnostic agent for detecting and Lane, Rockville, MD 20857, in Cancer Institute, 9609 Medical Center monitoring target-expressing Conference Room 5N76. Attendance by Drive, Mail Stop 9702, Rockville, MD malignancies the public will be limited to space 20850–9702, Tel. 240–276–5515 or Value Proposition: available. Interested persons may VerDate Sep<11>2014 18:36 Aug 15, 2016 Jkt 238001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\16AUN1.SGM 16AUN1

54584 Federal Register / Vol. 81, No. 158 / Tuesday, August 16, 2016 / Notices present data, information, or views, Environmental Response Policy and reason for each suggestion or orally or in writing, on issues pending Seventeenth District will meet on recommendation. before the committee. Written September 21, 2016, in Anchorage, We encourage you to submit submissions should be forwarded to the Alaska. The meeting will be used as an comments through the Federal contact person (below) on or before opportunity to discuss Alternative eRulemaking Portal at http:// August 19, 2016. Oral presentations Planning Criteria (APC) as they relate to www.regulations.gov. If your material from the public will be scheduled at the oil spill preparedness pursuant to vessel cannot be submitted using http:// conclusion of the meeting. Individuals response plan requirements. The www.regulations.gov, contact the person interested in making oral presentations meeting will be open to the public. In in the FOR FURTHER INFORMATION are encouraged to notify the contact addition, the comment period for the CONTACT section of this document for person on or before August 19, 2016. notice published May 27, 2016, is alternate instructions. Documents Five minutes will be allotted for each extended. mentioned in this notice, and all public presentation. DATES: The comment period for the comments, are in our online docket at The meeting may be accesed via notice published May 27, 2016 (81 FR http://www.regulations.gov and can be telephone. To attend on site, obtain the 33685) is extended. Comments and viewed by following that Web site’s call-in number and access code, submit related material must be submitted on or instructions. Additionally, if you go to written or brief oral comments, or before Friday, September 23, 2016. The the online docket and sign up for email request special accommodations for Coast Guard will meet Wednesday, alerts, you will be notified when persons with disabilities, please register September 21, 2016, from 8:30 a.m. to comments are posted or a final rule is on-line at http://nac.samhsa.gov/ 3:00 p.m. Please note that the meeting published. Registration/meetingsRegistration.aspx, We accept anonymous comments. All may close early if all comments have or communicate with SAMHSA’s comments received will be posted been heard. Designated Federal Officer, Ms. Nadine without change to http:// ADDRESSES: The meeting will be held in Benton (see contact information below). www.regulations.gov and will include the Robert Atwood Room (Room 104) on any personal information you have Substantive meeting information and the first floor of the Robert B. Atwood a roster of Committee members may be provided. For more about privacy and Building, 550 W. 7th Avenue, the docket, you may review a Privacy obtained either by accessing the Anchorage, AK 99501. Parking will be SAMHSA Committees’ Web site http:// Act notice regarding the Federal Docket available in the adjacent Lilly Pacillo Management System in the March 24, www.samhsa.gov/about-us/advisory- Parking Garage. Parking tickets can be councils/advisory-committee-womens- 2005, issue of the Federal Register (70 validated at the Atwood Building’s FR 15086). services-acws or by contacting Ms. Security Desk. Benton. For information on facilities or Public Meeting Committee Name: Substance Abuse and services for individuals with A public comment period will be held Mental Health Services Administration disabilities, or to request special during the meeting on September 21, Advisory Committee for Women’s Services assistance at the meeting, contact the 2016, from 12:00 p.m. to 3:00 p.m. (ACWS). person listed in FOR FURTHER Speakers are requested to limit their Date/Time/Type: Wednesday, August 24, INFORMATION CONTACT below, as soon as comments to 3 minutes. Please note that 2016, from: 9:00 a.m. to 5:00 p.m. EDT, open. possible. Place: SAMHSA, 5600 Fishers Lane, the public comment period may end To view the APC Guidelines, as well before the time indicated, following the Conference Room 5N76, Rockville, Maryland as public comments and any documents 20857. last call for comments. Contact the Contact: Nadine Benton, Designated mentioned in this notice, go to http:// individual listed below to pre-register as Federal Official, SAMHSA’s Advisory www.regulations.gov and type ‘‘USCG– a speaker. Pre-registration is not Committee for Women’s Services, 5600 2016–0437,’’ and click ‘‘Search.’’ Then required to speak at the meeting as Fishers Lane, Rockville, Maryland 20857, click ‘‘Open Docket Folder.’’ attendees will be able to note their Telephone: (240) 276–0127, Fax: (240) 276– FOR FURTHER INFORMATION CONTACT: CDR desire to speak via the on-site meeting 2252, Email: nadine.benton@samhsa.hhs.gov. Scott Stoermer, USCG Headquarters, attendance/registration form. Written Summer King, 2703 Martin Luther King Jr. Ave SE., comments may also be brought to the Statistician, Substance Abuse and Mental Stop 7516, Washington, DC 20593, meeting and will be included as part of Health, Services Administration. scott.a.stoermer@uscg.mil, (202) 372– the docket. Written comments [FR Doc. 2016–19422 Filed 8–15–16; 8:45 am] 2234. submitted to the docket via http:// BILLING CODE 4162–20–P SUPPLEMENTARY INFORMATION: This www.regulations.gov do not need to be public meeting is part of the public brought to the meeting. comment period already announced The U.S. Coast Guard Office of Marine regarding the draft National APC Policy Environmental Response Policy is DEPARTMENT OF HOMELAND (81 FR 33685). To facilitate public developing national-level policy to SECURITY participation, we are extending the clarify APC submissions and processes Coast Guard comment period and holding a public pursuant to Title 33 Code of Federal meeting, and we invite public comment Regulations, Part 155.1065 and [Docket No. USCG–2016–0437] 155.5067. While not a regulatory or rule- on the issues as listed in the ‘‘Agenda’’ making activity, the Coast Guard is asabaliauskas on DSK3SPTVN1PROD with NOTICES Update to Alternative Planning Criteria section below. Comments previously submitted do not need to be submitted aware of the impact of the policy related (APC) National Guidelines again. to APC and its critical role in tank and AGENCY: Coast Guard, DHS. non-tank vessel response preparedness. Submitting Written Comments The goals of this public meeting are to: ACTION: Extension of comment period and notice of public meeting. If you submit a written comment, (1) Inform public entities of the status of please include the docket number, Alternative Planning Criteria policy; (2) SUMMARY: Representatives from the U.S. indicate the specific material to which Inform public entities of the comments Coast Guard’s Office of Marine each comment applies, and provide a from earlier comment period(s); (3) VerDate Sep<11>2014 18:36 Aug 15, 2016 Jkt 238001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\16AUN1.SGM 16AUN1


Document Created: 2016-08-16 03:20:38
Document Modified: 2016-08-16 03:20:38
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation81 FR 54583 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR